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Abstract 
Malaria and helminth co-infection have been widely reported by other researchers. Despite the 
increasing knowledge on co-infection, the impact of helminths and malaria on humans and 
laboratory animal models remains uncertain. Furthermore, studies have associated co-infection to 
the induction of hypoglycemia. Accordingly, the effect of Plasmodium berghei ANKA and 
Trichinella zimbabwensis co-infection on haematology, blood glucose and insulin profiles was 
investigated in male Sprague-Dawley rats. The study was investigated using 168 Sprague-Dawley 
rats that were assigned into four groups of 42 rats each; control (C), P. berghei (Pb), T. 
zimbabwensis (Tz) and P. berghei (Pb) + T. zimbabwensis (Tz) co-infection groups. The Tz group 
was orally infected with 3 muscle larvae/g animal body weight of Tz strain (Code ISS1209) at day 
0. The Pb group received (1×105 PRBCs) of P. berghei ANKA using intraperitoneal injection and 
Pb + Tz co-infection group received 3 muscle larvae/g animal body weight at day 0 followed by 
intraperitoneal injection of 1×105 PRBCs at day 28 post-infection with Tz while the Control group 
was uninfected. Plasmodium berghei parasitaemia (%), Tz adult worms (AWs) and muscle larvae 
(ML), blood glucose, liver and muscle glycogen, insulin concentration as well as the cumulative 
body weight were determined. Results showed a significant increase in parasitaemia for Pb + Tz 
co-infection at day 3 and 4 PI compared to Pb group. Adult Tz worms and ML recovered showed 
no significant difference (P > 0.05) between the co-infection and the Pb group (P > 0.05). Blood 
glucose levels for co-infected group were also not significantly different compared to the control 
although the Pb group showed a decrease in blood glucose at day 7 and 14 PI. The co-infection 
group showed a higher mean glycogen accumulation compared to Tz group although there was no 
significant difference between the two groups. Tz group and Pb + Tz co-infection groups showed a 
decrease in liver glycogen at day 7 Pl and at day 14 PI. The Pb + Tz co-infection group showed a 
significant decrease in glycogen compared to the control. After Pb infection, there was a decline in 
insulin for both Tz and Pb + Tz co-infection whereas at day 7 only the Pb + Tz co-infection group 
presented a decrease in insulin compared to the control. Therefore, the current study revealed that 
co-infection increased Pb parasitaemia and glycogen levels without decreasing the host blood 
glucose concentration. Early increase in Pb parasitaemia demonstrated that co-infection could 
alleviate parasitaemia severity in the host.  
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CHAPTER 1: GENERAL INTRODUCTION 
 
1.1 Background of the study 
Malaria and trichinellosis are two common parasitic infections that pose an enormous health and 
economic burden to developing countries, especially Sub-Saharan African countries (Boraschi et 
al. 2008; Florey et al., 2012). The prevalence and burden of these diseases is correlated to little or 
no scientific attention, unavailability of vaccines and poor socio-economic conditions in affected 
countries that hinder the effective control and management of the diseases (Boraschi et al., 2008). 
According the World Health Organization world malaria report 2017, the current global death toll 
of malaria is 445,000 deaths and 216 million cases worldwide. Thus, highlighting the fact that 
malaria still presents a major global mortality, morbidity and burden in affected regions which still 
needs attention (Utzinger et al., 2012). 
Equally, trichinellosis which has been reported to be an emerging and re-emerging zoonotic 
disease, is estimated to be a threat to 10 million people in some parts of the world (Utzinger et al., 
2012; Mukaratirwa et al., 2016). This zoonotic disease is caused by species of the genus 
Trichinella, a tissue-dwelling nematode (Pozio et al., 2006; Mukaratirwa et al., 2016; Onkoba et 
al., 2016a), through eating raw or undercooked meat (Mukaratirwa et al., 2013). The detection of 
Trichinella parasite in wild and/or domestic animals and humans (Mukaratirwa et al., 2016) is 
indicative of the economic importance of this disease to humans, pig production and food safety, 
since it is associated with animals and their products (Gottstein et al., 2009). Therefore, 
trichinellosis has an effect on meat and meat products trading industries across the world (Gottstein 
et al., 2009). Despite the devastating effect of malaria and trichinellosis on the human host, their 
occurrence in the same area exposes the host to the transmission of both infections and co-infection 
is inevitable (Onkoba et al., 2015). As one of the highly endemic regions for both malaria and 
helminths, there is an overlap between both diseases in Sub-Saharan Africa (SSA), and individuals 
living in such an environment are prone to both malaria-helminthiasis infections such as 
trichinellosis (Graham et al., 2005; Su et al., 2005; Melo et al., 2010; Salazar-Castañon et al., 
2014). Although, no human cases of trichinellosis have yet been reported in Southern Africa, the 
parasite has a likelihood of causing future outbreak of human trichinellosis in SSA region because 
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of its ability to affect non-human primates thus increasing the risk through, movement of animal 
products, poor animal rearing system and interaction between humans and wildlife/livestock 
(Mukaratirwa et al., 2008; Mukaratirwa et al., 2013; Onkoba et al., 2016a). 
However, current studies have revealed that malaria and helminthiasis co-infection can decrease 
the severity of malaria, especially with P. falciparium (Melo et al., 2010). But, the interaction of 
parasites and their host might be synergistic or antagonist (Telfer et al., 2008) which could impact 
each other directly or indirectly (Cox, 2001) by either aggravating or amending the disease within 
human host (Graham et al., 2005). This could result in implications such as morbidity or mortality 
for both hosts (Salazar-Castañon et al., 2014). More so, recent studies on vertebrates have 
demonstrated that parasitic co-infection could have a valuable influence on disease severity, 
development and transmission dynamics (Telfer et al., 2008; Knowles, 2011). However, for a 
better knowledge of epidemiology, it is important to understand the cellular, molecular, 
immunological and physiological mechanisms in which the parasites infect the same host 
(Knowles, 2011), and how the host immune system can counteract this mixed interaction (Druilhe 
et al., 2005). 
 
1.2 Motivation 
Although several studies have attempted to explain the patterns and mechanisms of co-infection 
between malaria and helminths, these surveys have recorded series of pathological disorder 
associated to malaria and trichinellosis. Malaria is known to cause a range of pathological 
complications, which are associated with metabolic impediments, such as impaired kidney 
functions, cardiovascular and glucose homeostasis. Glucose homeostatic derangement caused by 
malaria is hypoglycemia, initiated by the high parasite demand for glucose from its host (Smith et 
al., 2005). However, suggested mechanisms responsible for the cause of hypoglycemia have been 
the depletion of gluconeogenic substrate such as thiamine and liver damage (Murambiwa et al., 
2013). Similarly, Trichinella infection has been reported to have an influence on blood glucose 
level and this has been demonstrated in mice (Wu et al., 2009), dogs (Reina et al., 1989) and 
humans (Buşilă et al., 1967) infected with Trichinella species. The cause of hypoglycemia, has 
been associated to the rapid growth of the parasite larvae during migration and when located in 
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their final niche (muscles), thus the parasite necessitates huge amount of glucose for their 
sustainability there by affecting the host glucose store (Wu et al., 2009; Gumede et al., 2003). Co-
infection studies on helminths and malaria have demonstration differential pathological feedback 
(Onkoba et al., 2015). These feedbacks are always contradictory and non-heterogonous, and there 
is also paucity of data from local and global burden estimates (Utzinger et al., 2012). It is against 
this background that this study seeks to understand the effects of Plasmodium berghei ANKA and 
T. zimbabwensis co-infection on blood glucose concentration in Sprague-Dawley rats. 
 
1.3 Aim 
 To determine the effect of Plasmodium berghei ANKA and Trichinella zimbabwensis co-
infection on blood glucose and insulin profile in male Sprague-Dawley rats. 
1.4 Specific objectives 
 To determine the effect of P. berghei ANKA and T. zimbabwensis co-infection on blood 
glucose and insulin levels in male Sprague-Dawley rats. 
 To determine the effect of P. berghei ANKA and T. zimbabwensis co-infection on liver 
and gastrocnemius muscle glycogen levels in male Sprague-Dawley rats. 
 
1.5 Thesis structure 
The thesis is structured in the form of chapters. Chapter 1 introduces the study, study motivation, 
aims and objectives of the study. 
Chapter 2 gives the literature review that reviews all current literature associated to the study and 
highlights the research gaps in the area. 
Chapter 3 gives the materials and methods of the study and provides details of the experimental 
procedure and data and analysis. 
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Chapter 4 reports the results and provides graphical representation and synthesis of all data that 
was analyzed. 
Chapter 5 Reports on the discussion, in this chapter the results are discussed in view of other 
studies. 
Chapter 6 reports on general conclusion and recommendation. 
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CHAPTER 2: LITERATURE REVIEW 
 
2.1. Introduction 
The prevalence of parasitic infection such as helminths is widespread in humid and tropical region, 
where they are easily transmissible. Likewise, parasitic protozoa such as malaria (Plasmodium 
spp.) are common in this region, with both infections having a huge impact in the world, 
particularly when they co-exist in the same host (Supali et al., 2010). Infections caused by these 
parasites within the host result in a variety of biochemical reactions such as modulation of energy 
metabolism, anemia, inflammations and nutrient deficiencies (Saric et al., 2010). Parasitic 
infection in animals and humans has been postulated to induce hypoglycemia, which has been 
reported in cases of Trichinella infection (Nishina et al., 2004), and malaria (Smith et al., 2005). 
Severe clinical conditions in patients are known to be exacerbated by hypoglycemia, such 
conditions include malaria, malnutrition, and intoxication (Barennes et al., 2005). The above 
conditions can further be aggravated and result in high morbidity and mortality rate as reported in 
sub-Saharan Africa (Barennes et al., 2005). Hypoglycemia associated with malaria has a 
significant contribution to approximately 22500 deaths recorded in African children under the age 
of five years (Barennes et al., 2005). Cases of comatose children have as well been linked to 
hypoglycemia, and the mechanism driving this is still obscure. In order to understand the driving 
mechanism, several suggestions have been reported to tie to the cause of hypoglycemia; these 
include stress, hypercatabolism, anaerobic glycolysis, gluconeogenesis (Barennes et al., 2005), and 
drug treatment such as quinine have also been described as a possible mechanisms leading to 
hypoglycemia in African children (Murambiwa et al., 2013).  
In this regard, this section presents a review on the effects of malaria, helminthiasis and co-
infections on glucose and insulin levels and how they are associated with hypoglycemia in the 
host, in order to establish research gaps.  
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2.2 Malaria infection and epidemiology 
Malaria is one of the most severe and deadly diseases of humans and animals in the world (Benelli, 
2016), ranking third among infectious diseases, next to Acquired Immune Deficiency Syndrome 
(AIDS) and tuberculosis (TB) (Murambiwa et al., 2013). Malaria infection is caused by the genus 
Plasmodium, a parasitic protozoan distributed by infected female Anopheles mosquitoes (Salazar-
Castañon et al., 2014; Benelli, 2016). Species of Plasmodium that cause malaria infection in 
humans include; P. falciparum, P. vivax, P. malariae, P. ovale, and P. knowlesi (Brooker et al., 
2007). However, most deadly species are P. vivax and P. falciparum, with P. falciparum being the 
most deadly species in Sub-Saharan Africa (Melo et al., 2010). The wide distribution of these 
pathogens across the globe is responsible for morbidity and mortality, especially in tropical 
countries (Salazar-Castañon et al., 2014). According to recent studies on malaria incidence, it is 
estimated to be a threat to close to 3.3 billion people and 1.2 deaths recorded (Melo et al., 2010). 
Most of the mortality is noticeable in the African continent, particularly in Sub-Saharan Africa, 
among children below the age of 5 years and pregnant women (Onkoba et al., 2015). The Sub-
Saharan region therefore serves as the core of parasite transmission. Even though recent studies 
on malaria have documented a marked decline in mortality up to about 54% in the African 
continent (Benelli, 2016), the disease still remains a serious public health threat that needs 
attention. 
 
2.3 Life cycle of Plasmodium spp. 
The transmission of malaria to the host (vertebrates such as humans), is through the Anopheles 
female mosquitoes (Crawley and Nahlen, 2004). Most life cycles of Plasmodium spp. occur 
through infected female Anopheles mosquito bite during blood meal, which releases infective 
sporozoites through the dermis into the peripheral blood circulation of the host. Sporozoites then 
migrate to the hepatocytes, where they duplicate through asexual schizogony to produce schizonts 
containing merozoites. The schizont ruptures and releases several merozoites which enter the 
blood stream. But, for the other species such as P. vivax and P. ovale the hypnozoites are formed 
which remain dormant in the liver until future stage; however, this does not happen with P. 
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falciparum (Trampuz et al., 2003). The process occurring in the liver is referred to as exo-
erythrocytic cycle which is usually asymptomatic as shown in Figure 1. 
The intra-erythrocytic or erythrocytic stage commences when the merozoites leave the liver and 
enter red blood cells (RBCs), developing into a ring form which later matures into trophozoites. 
During the ring stage, the parasite lies dormant for a while and becomes metabolically active after 
about 15 hours post invasion. There is therefore an increasing rate of metabolison and biosynthesis 
in the infected RBCs to finally mature into trophozoites (Kirk, 2004; Kirk, 2001). By so doing, it 
converts hemoglobin of the RBCs to aminoacid, and is also dependent on other nutrient sources 
for survival (Ramasamy, 1998; Milner et al., 2012). The malaria parasite relies on the host energy 
store because it has only a single mitochondrion but lacks a functional citric acid cycle; so it is 
dependent uniquely on glycolysis for its energy requirements (Kirk, 2004; Kirk, 2001). 
Trophozoites then undergo schizogony to form merozoites. The parasitized red blood cells 
(PRBCs) are lysed to release abundant merozoites, which enter blood circulation to recommence 
a new cycle of schizogony within the RBCs. Some of the merozoites in the blood stream develop 
into the male and female gametocytes (See Figure 1). 
These gametes are ingested by the mosquito during subsequent blood meal and undergo 
gametogenesis in the mosquito midgut. During this process, the gametocytes undergo fertilization 
to produce motile ookinete. The ookinete crosses the epithelial cell of the midgut into the 
haemocoele and develops into oocyst. The oocyst then produces sporozoites. The sporozoites 
formed in the mosquito migrate to the salivary glands ready for re-infection of the vertebrae host 
in another blood meal and the cycle resumes. The life cycle of malaria is similar in all species of 
Plasmodium. During the life cycle, the erythrocytes are modified in several ways. One of the ways 
is by deriving energy through anaerobic glycolysis of glucose to lactic acid contributing to 
manifestation of hypoglycemia and lactic acidosis (Milner et al., 2012). It is during this asexual 
cycle that most clinical manifestations are encountered. 
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Figure 1: Life cycle of Plasmodium spp. Hill (2011) 
 
2.3.1 Description of clinical features of malaria   
Clinical symptoms of malaria are felt during the erythrocytic stage of the lifecycle (Rosenthal, 
2008). Most of these symptoms ascend from the rupture of the schizont and destruction of the 
erythrocytes. However, the cycle of malaria might occur in some stages without specific symptoms 
and is a major concern in clinical and pathogenesis studies (Idro et al., 2010). Therefore, malarial 
manifestations may show resemblance with other viral infections, thus, making it difficult to 
diagnose (Trampuz et al., 2003). The most common clinical symptoms observed in infected 
individuals are; fever, headache, body weakness, prostration (Das, 2008). Additionally, vomiting, 
nausea, abdominal pain, myalgia, mild diarrhea, jaundice may occur (Trampuz et al., 2003). In 
cases of severe malaria there are no specific symptoms as well, but most are characterized by 
severe anemia, metabolic acidosis, jaundice, hyperlactemia, hypoglycemia, renal failure, 
pulmonary oedema, haemoglobinuria, abnormal bleeding, cerebral malaria and electrolyte 
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imbalance (Idro et al., 2010). Hypoglycemia and acidosis result from metabolic impediments 
(Trampuz et al., 2003), which are often associated with cerebral malaria during severe illness 
(Rosenthal, 2008). 
The above-mentioned symptoms might evolve speedily over a duration of an hour or days. In 
situations where all these complications are combined in a particular host, death comes as fast as 
possible probably within a few hours (Trampuz et al., 2003). Therefore, it is necessary for proper 
evaluation of a patient infected with malaria for any of these signs to avoid the disease severity 
which might lead to death through instant treatment (Trampuz et al., 2003). Although, studies have 
revealed that proper evaluation of clinical outcome in a patient could be influenced by other factors 
such as pregnancy, age, virulence of the parasite strain, inoculation host genetic factor and 
immunity, all these need to be taken into consideration before treatment (Legesse et al., 2004). 
 
2.3.2 Host-parasite interaction and pathophysiology of malaria 
The pathogenesis and clinical outcomes induced by P. falciparum is a multi-complex interaction 
(Buffet et al., 2011). Complications usually arise from an interplay between parasite and host, and 
might lead to multiple responses within the host. These responses could either be mechanical, 
humoral or immunological set to eliminate parasite but end up affecting the host (Elsheikha and 
Sheashaa, 2007; Mishra and Das, 2008). Once the host is infected, parasite-induced red blood cell 
alteration and microcirculatory abnormalities which lead to local and systemic reaction occur 
(Buffet et al., 2011). Malaria infection is known to be associated with severe anemia, cerebral 
malaria and metabolic acidosis, hypoglycemia, hypovolemia (Mockenhaupt et al., 2004).  
Hypovolemia, which has been identified as significant feature, might be exacerbated by the severe 
anemia caused by red blood cells destruction, metabolic acidosis, and microvascular impediment 
by sequestrated parasites resulting in the decrease delivery of oxygen to tissue (Mockenhaupt et 
al., 2004). Microcirculation perturbations might lead to decrease in metabolites exchange and 
hypoxia, and may trigger the release of pro-inflammatory and anti-inflammatory cytokines 
mediators (Clark and Cowden, 2003; Mockenhaupt et al., 2004; Murambiwa et al., 2013). Hypoxia 
has also been attributed to the disproportionate release of pro-inflammatory and anti-inflammatory 
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cytokine, hence, it has been associated to be the main factor in the pathogenesis of malaria (Clark 
and Cowden, 2003). Thus, understanding the host immune response is a vital contribution that will 
help unveil protective immunological strategies. Another main feature of the life cycle of P. 
falciparum is cytoadherence, whereby the mature parasitized red blood cells (trophozoites and 
schizonts), are capable of displaying significant change by and/or adhering to the endothelial cells 
(Rosenthal, 2008; Buffet et al., 2011; Cobbold et al., 2016). This could favor the parasite because 
the process can possibly obscure the passage of abnormal erythrocyte to the spleen (Rosenthal, 
2008). On the other hand, the adherence of mature PRBCs on small blood vessel obstructs the 
peripheral blood circulation, contributing to the pathogenesis of malaria (Buffet et al., 2011; 
Cobbold et al., 2016). However, the early stages (rings) of the infection present slight modification 
of adhesion or deformability, which can be seen within the blood circulation; hence, the level of 
peripheral parasitaemia could be quite low, since not all the intra-erythrocytic stages of the parasite 
are present in the blood circulation (Sherman et al., 2003; Rosenthal, 2008). 
 
2.3.3 Role of cytoadherence and sequestration of Plasmodium falciparum in pathogenesis of 
malaria 
Sequestration is a phenomenon in which the mature parasites adhere to the endothelial cells, blood 
cells and uninfected red blood cells. This is mediated by multiple host receptor recognized by 
parasite adhesine (Buffet et al., 2011). The accumulation of these parasites within the organs leads 
to variable clinical outcomes such as cerebral malaria, non-cardiogenic pulmonary edema and 
renal failure (Rosenthal, 2008). The consequence of sequestration may lead to mechanical 
obstruction of blood flow, which might lead to hypoxia, the release of parasites toxins and 
inflammatory mediators and cerebral oedema and neurological deficits (Beeson and Brown, 2002). 
In addition, parasite sequestration may concentrate metabolic disturbances and trigger pro-
inflammatory response to a particular organ such as the brain contributing to the severe clinical 
outcomes (Beeson and Brown, 2002). Studies have shown that individuals who progress to coma, 
might regain consciousness easily, therefore, this state could not be linked to neurological sequelae 
but rather signifying that the pathology of cerebral malaria is associated to metabolic components 
(Beeson and Brown, 2002). 
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2.4 Host–pathogen interaction and nutrient competition 
The host supports the parasite by providing a suitable environment for development, and this is 
based on an ecological and evolutionary perspective (Smith et al., 2005). Disease infection caused 
by pathogens and its manifestation comprises a series of ecological processes that occur within the 
host, which include, invasion, prey-predation dynamics, resources competition and consumption 
(Smith et al., 2005). Hence, host infection with pathogen, no matter the intensity of infection, 
decreases the host nutrients. Host nutrient supply is therefore strongly correlated to pathogen 
population growth and dynamics and pathological outcome (Smith et al., 2005). Increase in 
population of parasite results in increased demand of the host internal nutrient store (Goater et al., 
2013), while the host will suffer especially when valuable nutrients such as glucose are depleted 
(Smith et al., 2005). Competition of the large parasite population size and a single host for glucose 
uptake, results in hypoglycemia (Binh et al., 1997). 
 
2.4.1 Glucose metabolism by parasitized red blood cells during malaria 
The fact that the parasite within the infected erythrocytes need to survive and multiply, requires 
large amount of energy. Since the parasite has the ability to reproduce within 48 hours it therefore 
relies on the host energy store (Ginsburg and Stein, 2004). Thus, the parasite need to develop 
mechanisms to obtain nutrients from the host cytosol, consequently there is competition between 
metabolic and biosynthetic machinery of the host (Kirk, 2001). Most of the energy is critically 
required during the invasion of RBCs (ring stage) and the demand increases during the maturity to 
trophozoite (Kirk, 2001) which results in infected RBCs undergoing alteration of membrane 
transport (Sherman et al., 2003). Increasing membrane permeability of the infected red blood cell 
(iRBC) is of vital important to the parasites survival within the host, because the parasite is known 
to have a single mitochondrion and no functional citric acid cycle and hence dependent on 
glycolysis (Kirk, 2001) to meet its metabolic demand that cannot be provided by other endogenous 
sources from uninfected RBCs (Ginsburg and Stein, 2004). In such cases the developing parasites 
within the RBCs restructures the host cell, which becomes suitable for the transportation of large 
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number of proteins, there by facilitating nutrient transport, trafficking and evasion of host immune 
system (Cobbold et al., 2016). According to Kirk (2001) the amount of glucose used and lactic 
acid production in iRBCs increases 100 times compared to uninfected RBCs. 
 
2.4.2 Role of insulin in glucose metabolism 
Insulin is a hormone produced by pancreatic β- cells of the islet of Langerhans in response to 
elevated blood glucose and aminoacid. It is also well known to be the most potent anabolic 
hormone involved in tissue development and maintenance of the body glucose homeostasis (Saltiel 
and Kahn, 2001). The glucose regulatory hormones insulin and glucagon help to maintain the 
plasma glucose within narrow physiological range (Leto and Saltiel, 2012), by the interplay of the 
glucose-lowering action of insulin and the glucose-raising action of four counter regulatory 
hormones (catecholamines, cortisol, glucagon and growth hormone) (Thien et al., 2006). Insulin 
plays a vital role in most insulin-responsive sites by enhancing glucose uptake and inhibiting 
gluconeogenesis and glycogenlysis and reducing hepatic glucose uptake while increasing the rate 
of glucose uptake into striated muscles and tissues (Pessin and Saltiel, 2000; Saltiel and Kahn, 
2001). Glucose uptake from the circulatory system and into targeted tissue and fat is mediated by 
insulin- stimulated translocation transporter GLUT4 isoform to the cell surface (Leto and Saltiel, 
2012), thereby impacting lipid metabolism by increasing lipid synthesis in the liver and fat cells 
via the reduction of fatty acid from triglycerides in fat and muscles (Pessin and Saltiel, 2000). 
Despite the anabolic potentials of insulin in glucose metabolism, inadequate release of insulin in 
normal circulatory system in order to control glucose uptake leads to a defect in signals 
transduction, referred to as insulin resistance. Several mechanisms have been reported to be 
associated with insulin resistance, the molecular targets and intracellular signaling system that are 
modified during insulin resistance have received attention, yet, no evidence for the basic mutation 
in any signaling pathways (Pessin and Saltiel, 2000). However, insulin signaling mechanism has 
been reported to be involved in several glucose and lipid metabolism (Pessin and Saltiel, 2000) by 
participating in different processes such as cell growth and differentiation, apoptosis, protein lipid 
and glucose anabolism and catabolism. Insulin signaling pathway has been reported to play a 
central role in transporting glucose from blood to responsive tissues and stimulating the conversion 
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of glucose to glycogen to storage organs (Youngren, 2007). According to Wu et al. (2009), this 
pathway is activated by insulin, which binds with the receptor on cell surfaces of the insulin 
responsive tissues such as muscle. The insulin signaling pathway stimulates the binding process 
through the tyrosine phosphorylation of IR, insulin receptor substrate-1 (IRS-1) and IRS-2, which 
further activates phosphatidylinositol 3-kinase (PI3-K) (Youngren, 2007). Later the PI3-K also 
activates V-akt murine thymoma viral oncogene homologue (Akt) (Wu et al., 2009). Activated 
Akt then stimulates glucose uptake into cells by the help of glucose transporter 4(Glut4) from the 
intracellular storage sites to the plasma membrane (Wu et al., 2009).  
Glucose transporter 4 (Glut4) facilitates glucose uptake in muscle, and adipose tissue, and is 
expressed by activating the insulin receptor (MacIver et al., 2008). Insulin signaling has so far 
been reported in incident of malaria (Luckhart and Riehle, 2007) and Trichinella using 
experimental mice (Wu et al., 2009), which was underscored to induce hypoglycemia. 
Hypoglycemia in mice has been associated with hyperinsulinemia and its severe pathological 
outcome (Luckhart and Riehle, 2007). 
 
2.4.3 Effect of malaria on host glucose stores 
One of the most common complications during severe P. falciparum malaria is the host nutrient 
consumption by the parasite, and glucose is one of such nutrient (Smith et al., 2005). Consumption 
from the host glucose store by pathogenic protozoa is known to induce hypoglycemia (Smith et 
al., 2005; Thien et al., 2006), which implies that hypoglycemia is associated with the high rate of 
morbidity and mortality. In addition, most of the fatal incidences of hypoglycemia have been 
reported to have a higher frequency in children than adults, which has been observed in cases of 
comatose children with cerebral malaria (Barennes et al., 2005; Zijlmans et al., 2009). However, 
the pathological mechanism responsible for an imbalance between glucose production and 
utilization is still not clear (Dekker et al., 1997).  
During the life cycle of malaria in the vertebrate host, the erythrocytes are modified so as to derive 
energy through anaerobic glycolysis from glucose to lactic acid contributing to manifestation of 
hypoglycemia and lactic acidosis (Milner et al., 2012; Mehta et al., 2005). The iRBCs are solely 
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dependent on the host energy to meet the energy demand of the parasite, there by depleting the 
host energy store (Mehta et al., 2005) by competing with the metabolic and biosynthetic machinery 
of the host (Kirk, 2001). It is unquestionable that hypoglycemia is bound to occur since there is 
increased depletion of glucose by the parasite without sufficient replenishment from the host. 
According to Thien et al. (2006), the parasite intake of host glucose is known to be a contributing 
factor rather than a causative factor of hypoglycemia. Current reports have shown that iRBCs could 
use greater amount of glucose compared to non-infected RBCs (Mehta et al., 2005; Zijlmans et 
al., 2009). In addition, a severely ill person requires higher glucose demand compared to the 
parasite (Zijlmans et al., 2009). This has been demonstrated by Kochar et al. (1998) in a study of 
severe malaria cases in India, which reported that the mortality rate was higher in patients with 
low blood glucose (less than 2.2mmol/l) and a lower mortality rate in patients with blood levels 
greater than 3.3mmol/l.  
Hypoglycemia has well been reported to be exacerbated by hyperinsulinemia caused by quinidine 
in malaria treatment, as quinine stimulates insulin release (Trampuz et al., 2003).  
According to Thien et al. (2006),  
Plasma glucose concentration is maintained in the relatively narrow physiological range 
by the interplay of the glucose-lowering action of insulin and the glucose-raising action of 
four counter regulatory hormones (catecholamines, cortisol, glucagon and growth 
hormone).  
These hormones are involved in glucose homeostasis but the key counteracting regulators are 
insulin and glucagon. Insulin is involved in decreasing blood glucose while there are numerous 
glucose-increasing hormones (König et al., 2012). Although glucagon plays a primary counter-
regulatory role in hypoglycemia, epinephrine plays the secondary role and others such as thyroxine 
and cortisol play a minor role for the liver in conditions where there is decrease in effectiveness 
and response by glucagon (König et al., 2012). The concentration of insulin and glucagon in the 
plasma is released depending on the blood glucose concentration. Insulin functions by increasing 
glucose uptake pathways such as glycolysis and glycogenesis and decreases the production 
pathways such as gluconeogenesis and glycogenolysis, whereas a contrary process occurs for 
glucagon and other hormones (König et al., 2012). Other gluconeogenic substrates of importance 
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are thiamine and depletion of them has been reported by Krishna et al. (1999), and it is assumed 
to be caused by an increase in serum transketolase activities in patients with malaria in response 
to increased parasite glycolytic pathways. This results in decrease of host aerobic glycolysis and 
induces lactic acid accumulation (Murambiwa et al., 2013).  
Another possible cause of gluconeogenic substrate depletion resulting in hypoglycemia during 
malaria could be attributed to liver damage. Since the liver plays a vital role in glucose homeostasis 
by breaking down insulin receptor complex, any damage of the hepatocyte might delay the action 
of insulin receptor recycling, which might induce hypoglycemia (Murambiwa et al., 2013). 
According to Dekker et al. (1997), the hepatocellular destruction could occur during the rapid 
multiplication and change of phase within the liver by the malaria parasite. Therefore, the presence 
of hepatocyte cells within the extracellular fluid might be possible due to permeability of 
intracellular content of damaged hepatocytes. This is supported by studies carried out by Kausar 
et al. (2010) in which they observed an increase in liver enzymes such as alkaline transaminases, 
aspartate, alkaline phosphatase, suggesting the probability of liver damage. 
 
2.4.4 Diagnosis, treatment and prevention of malaria 
Most fatal records of malaria in many countries are attributed to late diagnosis and treatment. 
Therefore, for proper management of the disease, accurate diagnosis is required. Normally, malaria 
diagnosis is done by identifying the parasite or antigen/product in the blood, but is influenced by 
several factors. Some of these factors could be the different species causing malaria and their 
endemicity, level of transmission, the different stages of erythrocyte cycle, immunity, drug 
resistance, parasite sequestration and many more (Tangpukdee et al., 2009).  
However, the most widely used method of malaria diagnosis is based on clinical symptoms, which 
is known to be the traditional method. The majority of clinical diagnosis is done based on the 
patient clinical signs and symptoms and also on the physical examination (Tangpukdee et al., 
2009). However, the first symptoms of malaria are non-specific and show similarities with other 
viral and bacterial infections. This implies that the close similarities of malaria sign and symptoms 
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with other diseases make malaria diagnosis challenging. Furthermore, the non-specificity of 
clinical diagnosis might lead to misdiagnosis and eventually might result in wrong treatment. 
Another possible method of malaria diagnosis other than clinical pathology method is by using 
different laboratory techniques. The most common used laboratory techniques are microscopic 
diagnosis of thick and thin blood smears. Other concentration techniques include quantitative 
buffer coating (QBC), rapid diagnostic tests (example OptiMAL, ICT, Para-HIT-f, ParaScreen, 
SD Bioline, Paracheck) (Tangpukdee et al., 2009) and molecular diagnostic methods such as 
polymerase chain reaction (PCR). Some advantages and shortcomings of these methods have been 
described, related to sensitivity, specificity, accuracy, precision, time consumed, cost-
effectiveness, labor intensiveness, the need for skilled microscopists and technicians (Tangpukdee 
et al., 2009). Proper malaria control necessitates immense efforts and some of the currently used 
intervention strategies to control malaria include, use of insecticide-impregnated bed nets, house 
spraying and antimalaria drug administration to infected individuals (Brooker et al., 2007).  
 
2.5 Trichinellosis 
Trichinellosis is a meat-borne zoonosis, caused by parasitic tissue-dwelling nematode worm of the 
genus Trichinella (Mukaratirwa et al., 2016). The species are widely spread across the globe, 
without any documented incidence of the parasite infection in the Antarctica (Pozio et al., 2006; 
Pozio et al., 2007; Mukaratirwa et al., 2013). The detection of Trichinella parasite in wild and/or 
domestic animals and humans across the world reveals that it is a public health threat (Dupouy-
Camet and Murrell, 2007; Mukaratirwa et al., 2013). Also considering the fact that humans possess 
different ethnic habits regarding consumption of meat which could either be eaten raw or 
undercooked, hence promoting the transmission of the parasite (Pozio et al., 2007; Mukaratirwa et 
al., 2013). Although, other factors such as humoral, environmental and physiological might as well 
favor the transmission of Trichinella infection, the disease is regarded to be a huge burden to the 
public health sectors and the economy by the impact it causes to humans, pig production and food 
safety and meat trade (Gottstein et al., 2009). The disease burden levied to the society has prompted 
massive control and eradication efforts of the zoonotic pathogen from the food chain in developed 
countries (Gottstein et al., 2009) with little effort being made in developing countries. 
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2.5.1 Classification of Trichinella species 
Current taxonomical studies on the genus Trichinella have been based on the epidemiology, 
genetic diversity and zoogeographical distribution, resulting in the identification of eight species 
and four genotype (Gottstein et al., 2009; Mukaratirwa et al., 2013). The 12 recognized taxa are 
biologically and genetically categorized into two separate groups; the encapsulated and non-
encapsulated species based on the collagen capsule formed around the larvae within the muscular 
tissues of the host (Gottstein et al., 2009; Mukaratirwa et al., 2013). The encapsulated species 
include (Trichinella spiralis, Trichinella nativa, Trichinella britovi, Trichinella murrelli and 
Trichinella nelsoni) affecting mammals uniquely and two non-encapsulated species Trichinella 
pseudospiralis which infects birds and mammals only and Trichinella papuae and T. zimbabwensis 
that affect both mammals and reptiles (Mukaratirwa et al., 2008; Gottstein et al., 2009; Ludovisi 
et al., 2013). Out of the eight classified species, six and one genotype have been detected in humans 
(Arango et al., 2015), although there are no current documented cases of the prevalence of 
Trichinella infection in humans and animal in Sub-Saharan Africa, most infections were associated 
with Trichnella spiralis (Pozio et al., 2007). According to Mukaratirwa et al. (2013) the 
cosmopolitan, T. spiralis and T. pseudospiralis still remain undocumented in the Sub-Saharan 
region. However, recent reports have documented species such as T. britovi, T. nelsoni, T. 
zimbabwensis and Trichinella T8 to be present in Sub-Saharan Africa (Mukaratirwa et al., 2013). 
Trichinella zimbabwensis was first observed in Nile crocodiles (Crocodylus niloticus) and a 
carnivorous mammal (Panthera leo) (Mukaratirwa et al., 2013; Mukaratirwa et al., 2016). 
However, experimental studies have shown that T. zimbabwensis is infective to caimans, pythons, 
varans, and turtles (Pozio et al., 2007), rodents and domestic pigs (Mukaratirwa and Foggin, 1999) 
and non-human primates (Mukaratirwa et al., 2008). 
 
2.5.2 Geographical distributions and epidemiology of trichinellosis 
The distribution of the zoonotic pathogen Trichinella in animals and humans in the world, have 
been meat-borne (Mukaratirwa et al., 2013), and it is noticeable among ethnic communities around 
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the world due to their difference culinary habits with regards to meat consumption, which could 
either be raw or undercooked (Murrell and Pozio, 2011). The global impact of the disease have 
shown that 65 818 human trichinellosis incidence and 42 deaths have been reported world-wide 
and sub-Saharan Africa only contributing 0.04% of human trichinellosis and 3.6% mortality 
(Murrell and Pozio, 2011). According to recent reviews, eight species and four genotypes are 
documented across the world (Gottstein et al., 2009; Pozio et al., 2009) yet, there is minimal newly 
reported cases of Trichinella spp. infection in animals and humans in sub-Saharan African region 
(Mukaratirwa et al., 2013), except in a single review where ten sub-Saharan African countries were 
reported to have Trichinella spp. in animals and humans (Pozio et al., 2007). The species that have 
been described in sub-Saharan Africa (SSA) include T. britovi, T. nelsoni, T. zimbabwensis and 
Trichinella T8, however, the cosmopolitan T. spiralis and T. pseudospiralis have not yet been 
reported in SSA (Mukaratirwa et al., 2013).  
In West Africa, T. britovi has been reported in Guinea in true civet and palm civet and isolation of 
the Guinea strain through multiplex-PCR has been shown to be alike to the European reference 
strain (Pozio et al., 2005; Pozio et al., 2007). Also, the species that was responsible for the 
Trichinella infection in animal and humans in Senegal could possibly have been T. britovi (Pozio 
et al., 2005). Beside the documented incidence of T. britovi in West Africa, studies on Trichinella 
spp. in this region is scanty (Pozio et al., 2005; Pozio et al., 2007). Trichinella nelsoni has been 
reported to be restricted SSA countries (Pozio et al., 2005; Pozio et al., 2007) such as in Kenya, 
South Africa and Tanzania (Pozio et al., 1997; Marucci et al., 2009). In southern Africa Trichinella 
T8 has been reported in South Africa and Zambia and its presence in these countries could perhaps 
be linked to the passive introduction from Europe (La Rosa and Pozio, 2000). The occurrence of 
encapsulated larvae of T. britovi has been detected in wild carnivore, no animal or human case has 
been recorded, and in Algeria T. britovi was found in and domestic pig (Pozio et al., 2007). Two 
species have been detected in Egypt i.e. T. spiralis in stray dogs and domestic pigs and T. britovi 
in wolves (Pozio et al., 2007). 
Trichinella zimbabwensis has wide distribution in SSA, particularly in Southern Africa, and has 
been observed in countries such as Zimbabwe, Ethiopia, Mozambique and South Africa 
(Mukaratirwa and Foggin, 1999; Pozio et al., 2002; La Grange et al., 2013). However, knowledge 
of the geographical range of T. zimbawensis is increasing based on the increase in number of 
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identified isolates (Pozio et al., 2009). The T. zimbabwensis larvae was first detected in the muscle 
of farmed crocodiles (Crocodylus niloticus) in Zimbabwe (Pozio et al., 2002; Pozio et al., 2009) 
which represented the first observation of Trichinella in naturally infected reptiles and in 
poikilothermic animals (Pozio et al., 2009), so far, no human infection has been reported. In South 
Africa, the prevalence of T. zimbabwensis has been recorded in wild crocodiles in the Kruger 
National Park (KNP). In addition, two Trichinella taxa, Trichinella nelsoni and Trichinella T8 
have been found in Lions (Panthera leo) and spotted hyenas (Crocuta crocuta) in the KNP 
(Marucci et al., 2009; La Grange et al., 2013). Experimental studies have revealed that T. 
zimbabwensis can infect mammalian host such as rodents, pigs, carnivores and non-human 
primates (Mukaratirwa et al., 2008). Globalization of trade could intensify the danger of spread of 
the parasite through increased mobility of individuals, wildlife and livestock in and out of T. 
zimbabwensis endemic zones of southern Africa (Mukaratirwa et al., 2013). Therefore, it is of 
great epidemiological and public health interest. However, the control, surveillance and treatment 
of this disease is impeded by the range of domestic, synanthropic and sylvatic reservoir animals 
exacerbated by lack of a vaccine, licensed and efficient drugs against the muscle larvae and 
appropriate diagnostic tools which could be used to determine early infection (Onkoba et al., 
2016b). 
2.5.3 Host range and mechanism of spread of trichinellosis  
The parasite Trichinella has a vast range of hosts (Kapel and Gamble, 2000; Murrell and Pozio, 
2000). An understanding of the host range and geographical distribution of a parasite is vital and 
the fact that T. zimbabwensis reside in muscle tissue of several mammalian host and its wide 
distribution, suggests that there could be possible mechanism propelling its wide distribution. One 
such mechanisms could be related to ethnic meat eating habits (Mukaratirwa et al., 2013) or 
alternatively the spread of trichinellosis could possibly be through the scavenging activities of a 
variety of mammals on infected dead animals or cannibalism. According to Mukaratirwa et al. 
(2013) reports from field observation have demonstrated that Trichinella infection in wild 
carnivore sub-Saharan Africa, have maintained the sylvatic cycle through predation, scavenging 
and cannibalism.  
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2.6 Life cycle of Trichinella spp.  
The life cycle of all Trichinella spp. have an identical sequence to that of T. spiralis. The cycle 
occurs in host vertebrates such as (mammals, reptiles and birds) including humans (Mitreva et al., 
2004). Human trichinellosis is transmitted by eating raw or undercooked infected meat from pigs, 
wild boars, dogs, horses, walruses, bears and foxes (Gottstein et al., 2009) as shown in (Figure 2 
A). The cycle comprises of two phases within the host which includes the intestinal and enteral 
phase or enteric and muscle phase (Capo and Despommier, 1996; Mitreva et al., 2004) occuring 
within the host body  (Figure 2 B). Transmission from one host to the other occurs by consumption 
of infective muscle larva L1 (enteric phase). The enteric phase begins after ingestion of infective 
muscle larvae (ML1) (Mitreva et al., 2004; Wu et al., 2009), while in the stomach the ingested 
larvae are released by the action of pepsin hydrochloric acid and move to the small intestine where 
it invades the mucosal columnar epithelial cells creating an infection (Gottstein et al., 2009). The 
larva then undergoes development into an adult parasite and this occurs within a short period of 
time 2 days (Gottstein et al., 2009). In the course of development, complex interaction with the 
host is initiated before it finally matures to an adult parasite (Mitreva et al., 2004). Copulation 
between the male and female is known to occur between 30-34 hours post-ingestion of larvae 
(Capo and Despommier, 1996). The gravid female worm produces numerous immature first stage 
larvae or newborn larvae (NBL) in the intestinal mucosal. The NBL then enters the host portal 
venous and are dislodged via blood circulation into the host tissues (Gottstein et al., 2009). The 
muscle phase (parenteral) comprises significant transformations of the striated muscles by the first 
stage larvae causing intracellular infection thus inducing series of changes in the host  (Mitreva et 
al., 2004). Muscle cells infected by parasite cause pathological problems, thus transforming the 
muscle cells into another type of cell called nurse cell (see Figure 2) (Wu et al., 2009). 
Subsequently the process of calcification occurs over a period of time (weeks, months, or years) 
(Gottstein et al., 2009). 
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Figure 2: The life cycle of Trichinella spp. Gottstein et al. (2009).  
 
2.6.1 Clinical and pathological characterization of trichinellosis 
Manifestation of trichinellosis infection in humans is often subclinical, however the clinical 
manifestation presented often varies based on the phase in which the parasite occurs and the 
number of larvae consumed (Arango et al., 2015). This could result into a series of clinical 
outcome, which ranges from asymptomatic to mortality (Gottstein et al., 2009). The asymptomatic 
signs are normally indistinct due to the low intensity of the parasite consumed but when higher 
number of larvae are consumed, instantly there is gastroenteritis which is associated with diarrhea 
and abdominal pains which commence the acute phase of the disease (Gottstein et al., 2009). 
During the enteric phase, the basic signs which are noticeable after consuming infected larvae 
include diarrhea, vomiting, and abdominal discomfort. Other signs that follow happens within 1-
6 week in the systemic phase after larvae ingestion. This is followed by fever, myalgia, facial or 
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periorbital oedema, headache, fatigue, and weakness (Arango et al., 2015). Additional signs that 
might be observed in the course of infection include conjunctivitis, sub-lingual and maculopapular 
hemorrhages. The differential diagnosis of trichinellosis includes influenza, dermatomyositis, and 
viral gastroenteritis (Arango et al., 2015) and these clinical manifestations are commonly observed 
during the acute phase of infection. Observable complications in the chronic phase include 
encephalitis, neurological symptoms which are often subacute and secondary infections such as 
bronchopneumonia and sepsis, which usually occur later during infection (Gottstein et al., 2009). 
Initiation of clinical pathology is noticeable when the larvae is released into the intestinal mucosa, 
and migrates into vessels and the distribution to the final site of predilection, which are the skeletal 
muscles (Gottstein et al., 2009). Migratory larvae and their metabolites cause instant reaction, 
consequently resulting to immunological, pathological and metabolic disturbances and associated 
clinical manifestation observed (Gottstein et al., 2009). In addition, pathological complications 
arise in parenteral phase due to series of changes induced by the developing larval in muscle cells, 
some of these changes are dissolution and disappearance of myofibers, proliferation and 
differentiation of satellite cell, de-differentiation of muscle cells, re-entry and arrest of cell cycle 
and transforming it into nurse cell (Wu et al., 2009). Formation of nurse cells in the encapsulated 
species involves complex process such as growth, regeneration, differentiation, proliferation of 
cell cycle, regulation and transformation (Wu et al., 2008).  
 
2.6.2 Effect of trichinellosis on host glucose metabolism 
Parasitic infection depend on host environment for development (Smith et al., 2005), thereby 
inflicting variable disease signs and symptoms. Disease manifestations may arise as a result of 
invasion, predator-prey relationship, resource competition and consumption (Bohannan, 2000). 
The invasion of Trichinella larvae in muscle tissues, causes direct and indirect negative effects on 
host. Direct effects occur during larva migration while indirect effects arise due to inflammatory 
responses of the host (La Grange and Mukaratirwa, 2014). One of such effect of Trichinella 
parasite on the host is the depletion of glucose which leads to hypoglycemia in the host (Wu et al., 
2009). 
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Hypoglycemia caused by Trichinella has been reported in humans (Buşilă et al., 1967) and 
experimental animals such as dogs (Reina et al., 1989) and mice (Wu et al., 2009) although, the 
mechanism is still not clear. A hypothetical postulation from previous reviews states that “high 
glucose consumption by rapid growing parasites causes “hypoglycemia” (Wu et al., 2009). Some 
of the recent studies on trichinellosis have highlighted hypoglycemia in human host to be attributed 
to the rapid proliferation of larvae within the muscle cell, total increase of glycogen in infected 
tissues, huge amount of glycogen found in larvae, glucose absorbance by larvae during incubation 
in-vitro and metabolic activities associated with glucose metabolism in nurse cell (Montgomery et 
al., 2003; Wu et al., 2009) which could possibly be the causes of hypoglycemia in host. This is 
further supported by a study carried out by Wu et al. (2009) on T. spiralis and T. pseudospiralis 
infected mice and there was an observable decrease in blood glucose in the infected host, 
moreover, the kinetics of the blood glucose levels during infection also ties with the growth of 
muscle larvae and encystment of muscle cell. 
An alternative mechanism might be associated with tissues destruction as a result of parasite 
invasion, which could further lead to increase in membrane permeability, and hence leakage of 
fluid to adjacent cells or tissues (Gottstein et al., 2009; La Grange and Mukaratirwa, 2014). This 
process has been linked to an increase of creatine phosphokinase (CPK), lactate dehydrogenase 
(LDH), aspartate transaminase (AST) and alanine transaminase (ALT) in the blood (Kociecka, 
2000), suggesting the possibility of leakage of vital nutrient component such as glucose, resulting 
in hypoglycemia. 
Furthermore, nutrients are required for larvae invasion and growth, therefore, the larvae could 
proliferate by consuming one of such nutrient as glucose and according to Wu et al. (2008), the 
increase expression of insulin receptor in infected muscle tissue as shown by cDNA microarray is 
indicative of the high glucose demand within the cells. Still, the insulin signaling pathways 
increase demand for glucose, thus play a role in the conversion of glucose from blood to responsive 
tissues by increasing the number Glut4 in the membrane increasing glucose uptake for storage as 
glycogen (Youngren, 2007). Insulin responsive tissues such as adipose tissues and skeletal muscles 
binds with insulin at the receptor surface. 
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2.6.3 Diagnosis of trichinellosis 
Human trichinellosis disease often present a complicated diagnosis, since there are no specific 
clinical signs and symptoms, especially during the early stages, but the parasite detection at the 
later or chronic phase is also not easy (Gottstein et al., 2009). More so, the disease becomes more 
challenging to humans to resolve, since diagnosis in live animals is nonspecific as well, regardless 
of the amount of Trichinella spp. larvae ingested by host. Therefore, preventing human 
trichinellosis is by meat inspection to detect the larvae (Mukaratirwa et al., 2013). The non-
specificity of the disease has resulted in late diagnosis (Janse and Waters, 1995). However, 
suggested possibilities to avoid conflicting diagnosis of trichinellosis is to delineate the signs and 
symptoms from that of other diseases that might show some similarities, thus making diagnosis 
complicated. 
Diagnosis of Trichinella infection in humans is centered on clinical, laboratory and 
epidemiological findings (Kociecka, 2000). According to Gottstein et al. (2009) one of the three 
findings (clinical, laboratory and epidemiological) should point to the presumptive diagnosis of 
trichinellosis. The key clinical signs reported include, fever, muscle pain, facial oedema, 
gastrointestinal symptoms, retinal and subconjunctival hemorrhages, eosinophils and sublingual 
oedema. Experimental findings of trichinellosis in the laboratory could be based on muscle 
biopsies of Trichinella larvae and Trichinella-specific antibody response by indirect 
immunofluorescence, ELISA or Western blot (Mukaratirwa et al., 2013). Epidemiological 
investigations should tie with laboratory confirmation accompanied with evidence of consumption 
of under-cooked or raw meat or animal product by patients (Gottstein et al., 2009; Mukaratirwa et 
al., 2013). In SSA there is insufficient epidemiological reports of human trichinellosis due lack of 
expertise by physicians which is often obscured by the early diagnosis of the disease. Since most 
of the documented reports in SSA are based on clinical findings, muscle biopsies and an 
epidemiological link to ingestion of meat from bush pigs and/or warthogs this still leaves a gap in 
early diagnosis of trichinellosis (Mukaratirwa et al., 2013). 
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2.6.4 Treatment and control of trichinellosis 
Human trichinellosis treatment can be tackled based on the following criteria; the clinical severity 
of infection and species of the parasite involved (Mukaratirwa et al., 2008). Most recommended 
anthelmintic drugs for patients with trichinellosis are mebendazole, albendazole, 
glucocorticosteroids and preparations that compensate for proteins and electrolyte loss (Kociecka, 
2000; Gottstein et al., 2009). The first two drugs are not recommended during pregnancy and 
children below 2 years, so the best drug for this group is pyrantel, but it is active only against adult 
worms in the gut and has no effect against muscle larvae (Dupouy-Camet and Murrell, 2007; 
Bruschi and Dupouy-Camet, 2014). The most commonly use steroid is prednisolone, which may 
alleviate the general symptoms of the disease (Bruschi et al., 2002). 
 For an appropriate control of trichinellosis, quality meat inspection which involve trichinoscopy 
for the detection of larvae in muscle, community awareness campaign and public health education 
(Dupouy-Camet and Murrell, 2007; Enemark et al., 2015) is recommended. The targeted group 
for awareness should involve consumers and hunters of bush meat from protected areas, who need 
to be informed on the health implications and danger when ingesting raw or undercooked meat 
without inspection. The other safe and acceptable method to prepare these meats is by irradiation 
to inactivate Trichinella larvae and according to Gottstein et al. (2009) the methods such as use of 
microwave, curing, drying and smoking are considered unsafe for meat preparation as they do not 
kill the larvae. More so the freezing is an inappropriate measure to control trichinellosis although 
it can inactivate certain Trichinella spp. muscle larvae, but there are freeze resistant species like 
T. britovi (Gottstein et al., 2009). 
 
2.7 Malaria-trichinellosis co-infection 
Malaria and helminthiasis, which includes trichinellosis, are common parasitic infections, which 
are rampant in tropical and sub-tropical countries (Figure 3). The convergence of these parasite in 
the same epidemiological zone often result in mixed infection or polyparasitism (Supali et al., 
2010). And as such, malaria is known to have a higher prevalence amongst the poor rural 
communities (Su et al., 2005; Brooker et al., 2007; Onkoba et al., 2015), where there is high 
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predominance of soil transmitted-helminths (STHs) as shown in Figure 3 (Mwangi et al., 2006; 
Melo et al., 2010; Knowles, 2011). Individuals living in such epidemiological zones of co-
endemicity are predisposed to greater possibility of multiparasitism or polyparasitim, or co-
infection with both malaria and helminth infections (Figure 3) (Graham et al., 2005; Su et al., 2005; 
Melo et al., 2010; Salazar-Castañon et al., 2014; Onkoba et al., 2015).  
 
 
Figure 3: Map showing the epidemiological zones of malaria, helminths, tuberculosis and HIV 
Salgame et al. (2013).  
The transmission of mixed infections with more than one parasite is common in endemic areas, 
whereby there is a high probability of both parasites to co-exist within the same host (Cox, 2001). 
According to Cox (2001), mixed infections often lead to the association of two or more parasites 
belonging to different species and possessing different genotypes suggesting that their interaction 
within the host might be of variable degrees, either synergistic or antagonist (Telfer et al., 2008) 
and could impact each other directly or indirectly, either by aggravating or ameliorating the disease 
within the human host (Cox, 2001; Graham et al., 2005). The combination of different parasites 
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within a host can have an impact depending on the group of parasites and the site of predilection 
in the host.  
Despite the host’s health implications of co-infections, several epidemiological and laboratory 
studies on parasitic co-infection with malaria and helminths have never been harmonised, making 
it difficult to have a harmonized solution in targeting co-infection issues. The extreme deviation 
in conclusions from these studies can be attributed to the fact that the majority of the studies laid 
more interest on the immunological aspects, and not considering the non-immunological aspect 
(Onkoba et al., 2015). Human and animal studies have documented contrasting results. Some 
presented that malaria-helminth can exacerbate malaria severity (Le Hesran et al., 2004; Supali et 
al., 2010). An example has been demonstrated in co-infection studies with P. falciparum and 
Schistosoma mansoni resulting in an increase in hepatomegaly and splenomegaly of the host 
(Booth et al., 2004), and increased malaria frequency after infection with these parasites (Faye et 
al., 2008). While others have presented that it could enhance protection against malaria disease 
severity (Nacher, 2008; Onkoba et al., 2015), and a few reports have revealed no association 
between the parasites (Lyke et al., 2006; Mulei, 2011).  
The potential for a parasite to successfully commence an infection on the host depends on its initial 
immune response (Telfer et al., 2008). Although, most literature has shown that helminths are 
capable of modulating the immune system of its host in order to survive (Ateba-Ngoa et al., 2016), 
invading parasite often encounter a new immune environment which could determine the 
possibility of prior and present infection state (Salazar-Castañon et al., 2014). This can be 
supported by reports from other co-infection studies, which state that a single parasite cannot have 
a direct influence on disease outcome and establishment of the second parasite, thus, implying that 
a single parasite only plays a role in changing the immune response in a way that will probably be 
to the advantage of the second parasite establishing itself within the host (Onkoba et al., 2015). 
However, based on past review, the presence of Th1 and Th2 effector response is reversibly 
suppressed, in which theoretically, Th2 response are evoked towards helminth infection and is 
capable of suppressing pro-inflamatory Th1 response that causes immunopathology in 
Plasmodium infection (Salazar-Castañon et al., 2014). Therefore, helminth infections have been 
identified in numerous studies to have a strong potential in diminishing the immune response to 
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unassociated antigens of other parasites such as Plasmodium parasite (Metenou et al., 2011; Ateba-
Ngoa et al., 2016), which could imply that individuals with chronic helminth infection are 
suspected to have a decrease in malaria specific immune response to the host (Ateba-Ngoa et al., 
2016). Different malaria outcomes with different species of helminth have been reported in 
previous studies. Parasitic infection and its implication with regard to glucose homeostasis has 
been shown in the case of malaria (Smith et al., 2005) and Trichinella (Wu et al., 2009). The 
combined effect of malaria-Trichinella coinfection on host glucose metabolism is still obscure. In 
addition, there is paucity in knowledge on host glucose metabolism and its adaptive immune 
responses induced by P. berghei ANKA and T. zimbabwensis co-infection, acting as a barrier 
against the advancement and improvement of diagnostic tools, surveillances, and control and 
management strategies of the coinfected parasites in SSA. Based on this criterion, the present study 
seeks to further investigate the impact of P. berghei and T. zimbabwensis co-infection on host 
glucose and insulin store. 
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CHAPTER 3: MATERIALS AND METHODS 
 
3.1 Chemicals and accessories  
All Chemicals used in this study were sourced as shown:  
Isoform inhalation (Safeline Pharmaceuticals (PTY) LTD, Weltevreden Park, Rooderport, South 
Africa), The Ultrasensitive Rat Insulin ELISA kit ( Mercodia AB, Sylveniusgatan 8A SE-754-50 
Uppsala, Sweden); potassium hydroxide (KOH), sodium sulphate (Na2SO4), anthrone, glycogen 
powder from rabbit liver (Sigma-Aldrich chemical company Germany), Giemsa stain (Merk (Pty) 
Ltd 1Friesland drive, Modderfontein, Gauteng, 1645 South Africa) sulphuric acid (H2SO4) (BDH 
Chemicals LTD, Poole, England); Pepsin (from porcine gastric mucosa), hydrochloric acid (HCl). 
All chemical reagents were of analytical grade purchased from standard commercial 
pharmaceutical suppliers. 
 
3.2 Study animals 
Male Sprague-Dawley rats (90-150g) used in the experiment were bred and housed in the 
Biomedical Resource unit in the University of KwaZulu-Natal, Westville campus and maintained 
under standard laboratory conditions (22 ± 2°C, CO2 content of < 5000 p.p.m., relative humidity 
of 55 ± 5 % and illumination cycles of 12 hours light and 12 hours darkness and noise level of < 
65 decibels). The animals were allowed to have free access to heat-sterilized rodent pellet chow 
(Meadows, Pietermaritzburg, South Africa) and clean water was supplied ad libitum. 
 
3.3 Ethical considerations 
All experimental procedures in this study were conducted with the approval of Animal Ethics 
Research Committee of the University of KwaZulu-Natal under the ethical clearance number 
AREC/018/016 PD. Where applicable, we adhered to ARRIVE guidelines for reporting in vivo 
animal experiments (Kilkenny et al., 2012). 
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3.4 Experimental design 
The effect of P. berghei ANKA and T. zimbabwensis on blood glucose concentration was 
evaluated in 168 male Sprague-Dawley rats of body weight (90-150g). The animals were randomly 
divided into four different groups of 42 rats per group: Control group (n = 42), Trichinella 
zimbabwensis group (n = 42), Plasmodium berghei group (n = 42) and co-infection group (n = 42). 
Each group was further subdivided into n = 6 in a cage (Figure 3). The animal in each of the cages 
for all the groups had equal amount of food and water that was given daily. The beddings of the 
cages was cleaned after every 2 days. The experimental animals were grouped as follows:  
1) The control group (C) which was non-infected was given deionized water. 
2) The Plasmodium berghei group (Pb) was infected with 1×105 P. berghei ANKA parasitized 
RBCs through intraperitoneal injection (IP).  
3) The Trichinella zimbabwensis group (Tz) was infected with 3 muscle larvae/g animal body 
weight of crocodile-derived T. zimbabwensis strain (Code ISS1209) by oral gavage on day 0 
of the experimental study using an 18 G curved oral dosing needle. 
4) The co-infection group (Pb + Tz) was infected with 3 muscle larvae/g animal body weight of 
T. zimbawensis strain (Code ISS1209) through oral gavage at day 0 of the experiment and at 
day 28 the rats where co-infected with (1×105 PRBCs) of Plasmodium berghei ANKA using 
intraperitoneal injection. The experimental design is outlined in the following schematic 
diagram below (Figure 4). 
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Figure 4: A schematic diagram showing the 42-day experimental protocol design. Trichinella 
zimbabwensis induction was done on day 0 of the 42-day experimental protocol while P. berghei 
induction was done on day 28 of the experimental study, coinciding with presence of Trichinella 
muscle larvae in the rats skeletal muscle. 
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3.4.1 Plasmodium berghei induction  
Plasmodium berghei ANKA strain used to induce malaria infection in rats was kindly donated by 
the University of Cape Town, South Africa. Infection was induced in the Sprague-Dawley rats 
(90-150g) through single intra–peritoneal injection of P. berghei (1×105 parasitized RBCs) 
(Gumede et al., 2003). The control animals were injected with phosphate buffer saline vehicle. 
Confirmation of infection was done through microscopic examination of Giemsa-stained thin 
smears of rat-tail blood. 
 
3.4.2 Trichinella zimbabwensis induction 
Trichinella zimbabwensis parasite strain (Code ISS1209) were isolated from crocodile 
(Crocodylus niloticus) and maintained in male Sprague-Dawley rats at the Biomedical Research 
Unit (BRU) of the University of KwaZulu-Natal. Trichinella zimbabwensis larvae from infected 
rat carcasses were isolated using the artificial modified method of HCl-pepsin digestion according 
to (Mukaratirwa et al., 2003). The larvae recovered were used to infect experimental animal, and 
infective dose of each experimental rat was 3 muscle larvae/g animal body weight administered 
orally as described by (Mukaratirwa et al., 2001). 
  
3.5 Haematological profile 
Blood samples were collected from all the animals group through cardiac puncture and transferred 
into EDTA tubes for measurement of haematology parameters, using AC.T 5 diff Beckman-coulter 
counter machine (Maimi Florida USA) which automatically determine the red blood cell (RBC) 
count, white blood cell (WBC) count and percentage (%) haematocrit. 
  
3.6 Parasitaemia determination  
Thin blood smears were prepared each day on microscope glass slides from Pb mono-infection 
and Pb + Tz co-infection group rats, using blood from rats tail prick post-infection with P. berghei. 
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The smears were allowed to the air to dry freely for about 10 seconds and were fixed with 80 % 
methanol for approximately 30 seconds. After fixation the slides were stained using freshly 
prepared Giemsa stain (20 % Giemsa with 80 % 6.2 buffer) for 35-45 minutes and rinsed with 
water. Slides were allowed to air dry and parasite identification was done using standard compound 
microscope at 100X objective with immersion oil. Average percentage parasitaemia was obtained 
by counting the total number of RBCs and total of iRBCs in 5 different microscopic field of view 
and calculated as follows; 
 
A percentage parasitaemia of 15-20 % was considered a stable state for malaria. 
 
3.7 Trichinella muscle larvae burden and adult worm counts 
Trichinella parasite was considered to have successfully reached host muscle on day 28 post 
infection. Larvae determination was confirmed by digestion of the muscle tissue following the 
procedures of modified artificial digestion as described by (Mukaratirwa et al., 2003). Briefly, 
digestion procedure involves; Per each 100g of muscle tissue collected from the rat carcasses a 
digestive fluid mixture made of 16 ml of 25 % HCl, 20 g of pepsin and 2 liters of distilled water 
was prepared. The temperature of the digestive fluid was maintained at 37° in a beaker containing 
a magnetic stirrer for 35 minutes followed by sedimentation for 40 minute in a separating funnel, 
40ml of the digestive mixture was collected and allowed to settle for 10 minutes. Subsequent 
separation of the digestive fluid was carried out for another 10 minutes, and supernatant removed 
allowing the suspension containing the larvae which is transferred into a Petri-dish for 
quantification of larvae under a dissecting microscope at 20x magnification. The adult worms were 
also recovered from the experimental rats intestine using a modified protocol as described by Pozio 
et al. (2002). To achieve this, the intestines were split open longitudinally, using a sharp dissecting 
scissors and submerged in 0.85% saline solution. The intestines were then incubated overnight at 
27° and later washed with distilled water under a 212 μm sieve. The process of washing was 
34 
 
repeated 3 times. After washing the parasites were viewed and counted using a Zeiss Stemi DV4 
Stereo microscope at 20X.  
 
3.8 Blood glucose concentration measurement 
Blood was collected by tail prick using a sharp sterile needle daily at 0900 am for glucose 
measurement. These measurements were taken every three days from day 0 to day 42 as i.e; 0, 3, 
6, 9, 12, 15, 18, 21, 24, 27, 30, 33, 36, 39, and 42 and on the day of sacrifice (0, 7, 14, 21, 28, 35, 
and 42). Blood glucose measurement was done using a calibrated Accu-Check® Active (Roche, 
Randburg, South Africa) glucometer (Smith and Marais, 2004).  
 
3.8.1. Liver and muscle glycogen measurement 
The concentration of glycogen in the liver and muscle tissue was determined following a modified 
protocol as described by Ngubane et al. (2011). In this study 0.25-0.5g of tissue sample were 
homogenized in 2ml of 30% KOH (30g/100ml) and boiled at 100°C for 30 minute. Then, 0.15ml 
of 10% Na2SO4 (10g/100ml) was added into the tissue homogenates and vortexed. From each 
sample, 2μl was added to 2μl of 95% of ethanol, 1ml of de-ionized water and 4ml anthrone reagent 
(0.5g in 250ml of concentrated H2SO4) to extract the glycogen from the liver and muscle sample. 
Following similar procedure of tissues sample preparation, blanks were prepared, where the tissue 
samples in the blanks were replaced with 2μl of de-ionised water. Glycogen powder from rabbit 
liver was used to prepare standards solutions (10-2000 mg/1) which were also treated in the same 
way as tissue samples described above. Subsequently, all prepared solutions were vortexed for 10 
minutes before measuring the absorbance at 540nm using a Spectrostar Nano microplate reader 
(BMG Labtech Germany). A glycogen standard curve was prepared and used for the extrapolation 
of all tissue glycogen concentrations. 
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3.8.2 Serum insulin measurement 
To determine insulin concentration, blood samples were collected from the heart through cardiac 
puncture on each day of sacrifice (0, 7, 14, 21, 28, 35 and 42 PI) into the heparin tubes for serum. 
The blood samples were later centrifuged to separate the plasma and the serum. The measurement 
of insulin concentration was further done using Mercodia Ultrasensitive Rat Insulin ELISA Kit on 
the separated blood sera. All the reagents used were supplied by the manufacturer and the 
procedures for insulin assay was conducted as follows: The Insulin kit consists of a 96 well plate 
coated with mouse monoclonal anti-insulin, enzyme conjugate 11X, enzyme conjugate buffer, 
wash buffer 21X, calibrators 1,2,3,4,5, substrate 3,3',5,5'-tetramethylbenzidine (TMB) and a stop 
solution. The kit has a two sided solid phase immunoassay which function based on a technique 
of direct sandwich, in which two monoclonal antibodies are directed against separate insulin 
determinants on the insulin molecule. In the course of incubation, insulin in the sample reacts with 
peroxidase-conjugated anti-insulin antibodies bounds to a microtitration well. A simple washing 
steps was done to removes unbound enzyme labeled antibody. The bound conjugates were detected 
by reacting with 3, 3’-5, 5’ tetramethylbenzidine. The reaction was stopped by adding sulphuric 
acid (0.5M) to give a calorimetric end point that was read in spectrophotometer microplate reader 
(BMG Labtech Germany) at 450nm. The determination of each sample was performed in 
duplications of all standards. Subsequently an insulin standard curve was done and use to 
extrapolate the insulin concentration. 
 
3.9 Body weight determination 
The body weight of experimental animals were measured using a daily calibrated digital balance 
(Germany) for all groups (C, Pb, Tz, and Pb + Tz) after every three days (0, 3, 6, 9, 12, 15, 18, 21, 
24, 27, 30, 33, 36, 39, and 42) and on the day of sacrifice (0, 7, 14, 21, 28, 35, and 42).  
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3.9.1 Terminal Studies  
All the four experimental groups (C, Pb, Tz, Pb + Tz) were terminated by sacrificing (n = 6) from 
each of the group after every 7 days (0, 7, 14, 21, 28, 35, and 42). The animals were sacrificed by 
anaesthetizing them in an anesthetic chamber with 100mg/kg of isofor inhalation anesthetic for 3-
5 minutes. Blood samples were collected by cardiac puncture and put in heparin tubes which was 
later centrifuged to separate the serum. Separated blood sera was placed into Eppendorf micro-
centrifuge tubes and stored in -80°C Ultra-Bio Freezer in the University of KwaZulu-Natal and 
was later used to measure insulin concentration. The following organs were harvested (kidneys, 
liver, pancreas, heart, spleen, muscles) and weighed using a calibrated gravimetrical balance. 
 
3.10 Data Analysis 
The data obtained from adult worms recovered in the intestines and the number of muscle larvae 
were counted in five microscopic field of view and their mean values were used for analysis. The 
level of malaria parasitaemia was assessed from five different fields of view to obtain the mean in 
percentage which was used for the analysis. The muscle and liver glycogen OD values were 
extrapolated from the standard curve OD values and the mean of the extrapolated data was 
analyzed. 
The differences in the measured parameters; blood glucose, insulin, liver glycogen, muscle 
glycogen, % parasitaemia, % hematocrit and Trichinella muscle larvae burden in all the groups 
were expressed as mean ± standard error (SEM). Statistical significance between the control, 
malaria, Trichinella and co-infection experimental groups were determined by Two Way Analysis 
of Variance (ANOVA) followed by multiple comparison Bonferroni post-test analysis. All the 
statistical analysis and graphs were done using a GraphPad InState software (version 5.00, 
Graphpad software, San Diego, California, USA). P < 0.05 was considered statically significant. 
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CHAPTER 4: RESULTS 
 
4 General 
This chapter describes the following: 
Percentage parasitaemia in P. berghei infected experimental animals, Trichinella muscle larvae 
burden, haematology parameters, cumulative body weight, blood glucose concentration in all the 
experimental groups, liver and muscle glycogen concentration of the experimental groups and 
serum insulin concentration of the experimental groups as presented in subsequent sections. 
 
4.1 Percentage parasitaemia after P. berghei infection  
The mean parasitaemia and standard error of mean after Plasmodium berghei induction of the 
experimental groups are shown in Figure 5. The result shows that the percentage (%) P. berghei 
parasitaemia increases for both P.berghei mono-infection and P. berghei + T. zimbabwensis co-
infection groups at day 1 PI and 2 PI respectively (P > 0.05). Subsequently, at day 3 PI and 4 PI 
% P. berghei parasitaemia was elevated for Plasmodium berghei (Pb) + Trichinella zimbabwensis 
(Tz) co-infection compared to P. berghei mono-infection (P < 0.01). However, we observed that 
the peak % parasitaemia for P. berghei mono-infection group was reached earlier at day 7 PI (67.4 
%) whilst the co-infection group peaked % parasitaemia occurred later at day 8 PI (69.2 %) with 
no significant difference (P > 0.05). After the peak % P. berghei parasitaemia was attained both 
Pb mono-infection and Pb + Tz co-infection groups decreased progressively till the end of the 
experiment (day 14 PI) but the co-infection group still maintained a higher % P. berghei 
parasitaemia compared to the P. berghei mono-infection group (P > 0.05). 
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Figure 5: Mean percentage parasitaemia (± SEM) in male Sprague-Dawley rats infected with 
Plasmodium berghei mono-infection (Pb) and P. berghei (Pb) + Trichinella zimbabwensis (Tz) 
co-infection. Day 0 of P. berghei induction represent day 28 post Trichinella zimbabwensis 
infection in rats when the muscle larvae are in the rat muscles. ** indicates P < 0.01 when 
comparing P. berghei mono-infection and P. berghei + Trichinella zimbabwensis co-infection. Pb 
= Plasmodium berghei and Tz = Trichinella zimbabwensis. 
 
4.2 Trichinella zimbabwensis adult worms and muscle larvae burden 
The number of Trichinella zimbabwensis adult worms recovered from the intestines of the 
experimental rats infected with Trichinella zimbabwensis (Tz) mono-infection and Plasmodium 
berghei (Pb) + T. zimbabwensis (Tz) co-infection at day 7 PI, 14 PI and 21 PI are shown in Figure 
6. The results show that there was no significant differences (P > 0.05) between number of adults 
recovered from the Tz mono-infection and Pb + Tz co-infection. However, the Tz mono-infection 
had slightly higher mean number of adult worms recovered (18.5 AW) compared to Pb + Tz co-
infection (15 AW) at day 7 PI whereas at day 14 PI few AW were recovered showing no statistical 
significance (P > 0.05). At day 21 PI no AW or ML was recovered from both Tz mono-infection 
and Pb + Tz co-infection groups. The number of muscle larvae burden increases progressively 
from day 28 PI, 35 PI, and peaking at day 42 for both Tz mono-infection and the Pb + Tz co-
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infection with no significant difference (P > 0.05) when compared to each other. At day 42 ML 
(Ipg) recovered from the Tz mono-infection was higher (97.4 Ipg) compared to the Pb + Tz co-
infection (71.6 Ipg) although not statistically significant (P > 0.05). 
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Figure 6: Mean number of adult worms (± SEM) of Trichinella zimbabwensis recovered at day 7 
PI, 14 PI and 21 PI and Mean (± SEM) muscle larvae burden recovered at day 28 PI, 35 PI and 42 
PI. After Tz mono-infection and Pb + Tz co-infection in male Sprague-Dawley rats. All values are 
expressed as mean ± SEM (n = 6 in each group). AW = Adult worms; ML = Muscle larvae; lpg = 
larvae per gram of muscle; Tz = Trichnella zimbabwensis; Pb = Plasmodium berghei. 
 
4.3 Cumulative body weight gain 
The cumulative body weight changes of experimental animal after post infection are shown in 
Figure 7. We observed that P. berghei (Pb) + Trichinellla zimbabwensis (Tz) co-infection group 
gained weight steadily from day 0 PI up to day 42 PI. Significantly, the cumulative weight gained 
was (P < 0.001) at day 14 PI, 21 PI, 28 PI respectively, (P < 0.01) at day 35 PI while day 42 PI 
was (P < 0.05) compared to the control group. Trichinellla zimbabwensis (Tz) mono-infection, 
also present a steady weight gained from day 0 PI to 42 PI, with a significant weight gain at day 
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14 PI (P < 0.001), 28 PI, (P < 0.01) and 42 PI (P < 0.05) compared to control. The P. berghei 
mono-infection correspondingly shows a consistent weight gained from day 0 PI up to day 35 PI 
showing no significant difference (P > 0.05) compared to the control. Subsequently, there was a 
significant (P < 0.001) weight loss at day 42 PI for Pb mono-infection compared to the control. 
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Figure 7: Cumulative body weight of male Sprague-Dawley rats infected with Plasmodium 
berghei (Pb) mono-infection, Trichinella zimbabwensis (Tz) mono-infection, P. berghei (Pb) + 
Trichinellla zimbabwensis (Tz) co-infection and non-infected control (C). All values were 
expressed as mean ± SEM (n = 6 in each group). Level of significance * P < 0.05, ** P < 0.01 *** 
P < 0.001 was obtained by comparing with the control. Tz = Trichnella zimbabwensis; Pb = 
Plasmodium berghei. 
 
4.4 Blood glucose concentration  
The mean blood glucose after P. berghei infection were compared between the control and the 
infected groups (Trichinella zimbabwensis mono-infection (Tz), Plasmodium berghei mono-
infection (Pb), Trichinella zimbabwensis (Tz) + Plasmodium berghei (Pb) co-infection) are shown 
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in Figure 8. At day 0 PI the mean blood glucose concentration for all infected groups showed no 
significant difference (P > 0.05) compared to non-infected control group. The blood glucose later 
decreases significantly (P < 0.05) at day 7 PI for Pb mono-infection whereas the Tz group and Pb 
+ Tz groups showed no significant difference (P > 0.05) compared to the control. Later at day 14 
PI the blood glucose dropped significantly (P < 0.001) for Pb mono-infection while Tz mono-
infection and Pb + Tz co-infection still presented no significant difference (P > 0.05) compared to 
the control.  
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Figure 8: Mean blood glucose concentration (± SEM) in male Sprague-Dawley rats infected with 
Trichinella zimbabwensis mono-infection (Tz), Plasmodium berghei mono-infection (Pb), 
Plasmodium berghei (Pb) + Trichinella zimbabwensis (Tz) co-infection and non-infected control 
groups. Day 0 of P. berghei induction represent day 28 post Trichinella zimbabwensis infection in 
rats when the muscle larvae are in the rat muscles. Values are presented as means and vertical bars 
indicate mean ± SEM (n = 6 in each group). Level of significance * P < 0.05, ** P < 0.01 *** P 
< 0.001. Tz = Trichnella zimbabwensis; Pb = Plasmodium berghei. 
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4.4.1 Liver glycogen concentration  
The liver glycogen concentration after P. berghei infection are shown in Figure 9. At day 0 PI all 
infected groups (Trichinella zimbabwensis mono-infection (Tz), Plasmodium berghei mono-
infection (Pb), Plasmodium berghei (Pb) + Trichinella zimbabwensis (Tz) co-infection) showed 
no significant difference (P > 0.05) compared to non-infected control. Significantly, the liver 
glycogen concentration decreases at day 7 PI for Pb + Tz co-infection and Tz mono-infection (P 
< 0.01 and P < 0.001) respectively while the Pb mono-infection present no significant difference 
(P > 0.05) compared to the control group. We also observed a significant (P < 0.05) decrease in 
liver glycogen concentration at day 14 PI for Pb + Tz co-infection group compared to the control 
group, while the Tz mono-infection group liver glycogen concentration was restored back (P < 
0.05) compared to the control. The P. berghei mono-infection infection had no significant change 
(P > 0.05) compared to the control at day 14 PI. 
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Figure 9: Mean liver glycogen concentration (± SEM) in male Sprague-Dawley rats infected with 
Trichinella zimbabwensis mono-infection (Tz), Plasmodium berghei mono-infection (Pb), 
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Plasmodium berghei (Pb) + Trichinella zimbabwensis (Tz) co-infection and non-infected control 
groups. Day 0 of P. berghei induction represent day 28 post Trichinella zimbabwensis infection in 
rats when the muscle larvae are in the rat muscles. Values are presented as means and vertical bars 
indicate SEM (n = 6 in each group). Level of significance indicated as * P < 0.05, ** P < 0.01, 
*** P < 0.001. Tz = Trichnella zimbabwensis; Pb = Plasmodium berghei. 
 
Muscle glycogen concentration 
The muscle glycogen concentration (± SEM) presented no significant difference (P > 0.05) 
between the T. zimbabwensis mono-infection and Plasmodium berghei (Pb) + Trichinella 
zimbabwensis (Tz) co-infection (Figure 10). Muscle glycogen accumulation increased 
progressively from day 0 PI, 7 PI and 14 PI for both infected groups (Tz mono-infection and Pb + 
Tz co-infection). However, the co-infection group presented a higher mean muscle glycogen value 
at day 7 PI and 14 PI (0.244 and 0.279 mg/tissue) respectively compared T. zimbabwensis single 
infection (0.185 and 0.19 mg/ tissue) respectively. 
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Figure 10: Muscle glycogen concentration (± SEM) in male Sprague-Dawley rats infected with 
T. zimbabwensis mono-infection and Trichinella zimbabwensis (Tz) + Plasmodium berghei (Pb) 
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co-infection. Day 0 of P. berghei induction represent day 28 post Trichinella zimbabwensis 
infection in rats when the muscle larvae are in the rat muscles. Values are presented as means and 
vertical bars indicate SEM (n = 6 in each group); Level of significance (P > 0.05) obtained by 
comparing Tz mono- infection and Tz + Pb co-infection. Tz = Trichnella zimbabwensis; Pb = 
Plasmodium berghei. 
 
4.4.2: Haematology measurements. 
Mean red blood cells count (RBC), white blood cell count (WBC) and % haematocrit are shown 
in Figure 11 below. In Figure 11 A; we observed that at day 0 PI there was no significant (P > 
0.05) change in RBC count in all infected group (P. berghei mono-infection (Pb), Trichinella 
mono-infection (Tz) and Plamodium berghei (Pb) + Trichinella infection (Tz) co-infection) 
compared to the control group. This was followed by a decrease in RBC count at day 7 PI for 
Trichinella mono-infection (Tz) and Trichinella infection (Tz) + Plamodium berghei (Pb) co-
infection group (P < 0.001) respectively compared to control while Pb mono-infection also 
decrease at day 7 PI although not significant when compared to the control. The co-infection group 
(Pb + Tz) and Pb mono-infection start to increase again at day 14 PI and was statistically non-
significant (P > 0.05) when compared to control group while the Tz group also increases but, still 
there was a significant difference (P < 0.05) compared to the control. 
We observed no significant difference (P > 0.05) of WBC count in all infected groups at day 0, PI, 
7 PI and 14 PI (Figure 11 B) compared to control. However, at day 7 PI and 14 PI there was 
increase in WBC count for Tz mono-infection, Pb mono-infection and Pb + Tz co-infection at day 
7 PI and 14 PI but, still not significant (P > 0.05). 
 
The percentage (%) haematocrit shown in (Figure 11 C) indicated that at day 0 PI all infected 
groups were not statistically significant (P > 0.05) compared to the control group. Significantly at 
day 7 PI P. berghei mono-infection (Pb), T. zimbabwensis mono-infection (Tz) and P. berghei T. 
zimbabwensis co-infection (Pb + Tz) decreases significantly (P < 0.01 and P < 0.001) respectively. 
At day 14 PI the Pb, Tz, and Pb + Tz group increases and were not significant compared to the 
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control although the Tz and Pb+ Tz was higher than the control the was no statistical difference in 
all of these groups. 
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Figure 11: Mean (± SEM) red blood cell (RBC); % haematocrit and white blood cell (WBC) 
concentrations in experimental rats infected with Trichinella zimbabwensis mono-infection (Tz), 
Plasmodium berghei mono-infection (Pb), Plasmodium berghei (Pb) + Trichinella zimbabwensis 
(Tz) co-infection and non-infected control groups. Day 0 of P. berghei induction represent day 28 
post Trichinella zimbabwensis infection in rats when the muscle larvae are in the rat muscles. 
Values are presented as means and vertical bars indicate SEM (n = 6 in each group). Level of 
significance indicated are * P < 0.05, ** P < 0.01, *** P < 0.001 was obtained by comparing with 
the control. Tz = Trichnella zimbabwensis; Pb = Plasmodium berghei. 
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4.5 Serum insulin concentration 
Insulin concentration decreases significantly (P < 0.01) for both Trichnella mono-infection (Tz) 
and Plasmodium berghei (Pb) + Trichinella zimbabwensis (Tz)  co-infection at day 0 PI while P. 
berghei mono-infection show no significant change (P > 0.05) compared to the non-infected 
control (Figure 12). Later at day 7 PI there was a significant (P < 0. 05) decrease in insulin for co-
infection group only, however, the Tz mono-infection and Pb mono-infection decreases but was 
not statistically significant (P > 0.05) compared to the control. At day 14 PI there was no significant 
(P > 0.05) change in insulin concentration for all infected group Pb mono-infection, Tz mono-
infection and Pb + Tz co-infection comparison to the control.  
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Figure 12: Insulin concentrations in experimental male Sprague-Dawley rats infected with 
Trichinella zimbabwensis mono-infection (Tz), Plasmodium berghei mono-infection (Pb), 
Plasmodium berghei (Pb) + Trichinella zimbabwensis (Tz) co-infection and non-infected control 
groups. Day 0 of P. berghei induction represent day 28 post Trichinella zimbabwensis infection in 
rats when the muscle larvae are in the rat muscles. Values are presented as means and vertical bars 
indicate SEM (n = 6 in each group). Level of significance * P < 0.05, ** P < 0.01, *** P < 0.001 
by comparing with the control. Tz = Trichnella zimbabwensis; Pb = Plasmodium berghei. 
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CHAPTER 5: DISCUSSION 
Findings from the current study show that the development of Pb in male Sprague-Dawley rats co-
infected with Tz is enhanced. Our study agrees with similar studies although co-infection was with 
a protozoan parasite. For example, mice co-infected with Trypanosoma brucei and P. berghei 
showed a rapid development of P. berghei with an increased P. berghei parasitaemia for the co-
infected mice than only P. berghei infected (Ademola and Odeniran, 2016). In another study by 
Bucher et al. (2011), they also reported increased early parasitaemia for co-infected S. mansoni 
and P. berghei mice than single infected S. mansoni mice. The elevated parasitaemia for the co-
infection group suggests that T. zimbabwensis chronic infection might potentially predispose the 
host to more severe infection.  
The occurrence of adult worms(AW) in the intestine of Tz mono-infection and co-infection 
persisted up to day 14 PI and no worms were recovered at day 21 PI onwards. Previous study by 
Onkoba et al. (2016a) have also demonstrated the persistence of AW of T. zimbabwensis in the 
intestine of mice at day 7 PI and 14 PI and a fewer number of ML at day 21. The non-appearance 
of AW at day 21 PI in the current study suggests that the majority of AW might have been 
eliminated by the host immune system. More so, day 21 PI might also indicate the appropriate 
time that most adult worms will have been killed by the host immune system. According to Bruschi 
and Chiumiento (2012), the successful establishment of Trichinella parasite in a host, primarily 
depends on their ability of the larvae to escape the host immune response. In addition, the 
persistence of AW in the intestine of hosts with recurrent exposure to infection has been thought 
to be associated with the down regulation of the immune response of the intestine or premonition 
state induced by continuous antigen stimulation (Bruschi and Chiumiento, 2012), thus suggesting 
that immune mechanism play a role in the process of deworming. 
Steady weight gain was observed in rats infected with Tz mono-infection and Pb + Tz co-infection 
group. However, the Pb mono-infected group had weight loss at day 42 PI compared to the control. 
Previous studies have shown that malaria and helminthiasis co-infection can decrease the severity 
of malaria, especially with P. falciparium (Melo et al., 2010). The fact that chronic Pb + Tz co-
infection was associated with weight gain confirms the synergistic interaction of parasites and their 
host during pathogenesis of malaria (Telfer et al., 2008). Therefore, we speculate that Tz + Pb co-
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infection may possibly ameliorate the disease severity inflicted by P.berghei within the host 
(Graham et al., 2005). 
There was a reduction in RBCs count and percentage haematocrit in rats infected with Pb mono-
infection, Tz mono-infection and Pb + Tz co-infection a week after infection, with an increase in 
the subsequent week. Previous studies have reported malaria infection to be associated with 
anemia (Mishra et al., 2002; Maina et al., 2010). Certainly, the manifestation of anemia during 
malaria infection might have a direct effect by reducing the percentage haematocrit and RBCs. 
However, it is thought that most malaria induced anemia ascend from the rupture of schizonts and 
destruction of erythrocytes (Idro et al., 2010). Contrary to another study which reported that the 
pathogenesis of anemia caused by malaria infection does not depend on peripheral blood 
destruction (Ademola and Odeniran, 2016). Surely, increase in parasitaemia, may result in 
excessive haemolysis of parasitized RBCs thereby inducing anaemia. In our study, it is shown that 
increased parasitaemia in infected groups is consistent with reduction of RBCs and haematocrits. 
Following previous studies, anemia increases with increase parasite density (Ademola and 
Odeniran, 2016). Thus, the pathophysiology of anemia involves multiple mechanisms which are 
inconclusive such as, destruction of RBCs (Clark and Cowden, 2003) and decreased production of 
RBCs (Ademola and Odeniran, 2016). However, the current study could not provide appropriate 
mechanisms involved in RBCs and haematocrit reduction. Additionally, we observed increased 
WBCs for single infection groups (Pb and Tz) and co-infection. Akin-Osanaiye et al. (2015) also 
reported increases in white blood cell count and parasitaemia during infection of albino mice and 
no significant increase after treatment. This is suggestive that the white blood cell plays an integral 
part during parasitic infections by regulating the host immune system to combat foreign pathogens 
directly via the process of phagocytosis. Therefore, it is certain that an increase in WBC due to co-
infection helps in the expulsion of the P. berghei parasite there by suppressing the effect on the 
host. Our study affirm that T. zimbabwensis promotes the production of WBCs, which helps in 
suppressing the P.berghei parasite there by counteracting the pathological effect due to the 
protozoan parasite. 
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Co-infection with P.berghei and T. brucei has demonstrated a blood glucose lowering effect in 
mice (Ademola and Odeniran, 2016). Contrary to our study, co-infection with P. berghei (Pb) + 
T. zimbabwensis (Tz) did not alter the blood glucose level, likewise Trichinella (Tz) mono-
infection, however, the P.berghei (Pb) mono-infection showed a reduction in blood glucose. 
Plasmodium berghei parasite has been reported to cause hypoglycemia in mice (Wu et al., 2009). 
Our study asserts that, P. berghei parasite decreases blood glucose which manifests after peak 
parasitaemia by which we assume that the parasite is dependent on the host energy store and 
thereby creating an imbalance between the host’s energy supply and demand (Kirk, 2001; Mehta 
et al., 2005). According to Olszewski et al. (2009) metabolic disturbance in glucose is a complex 
balance between supply, utilization, transportation and storage.  
Across the parasite membrane there is increasingly uptake of glucose through the process of 
glycolysis facilitated by hexose transporters Glut4 through the process of facilitated diffusion 
(MaIver et al., 2008, Ademola and Odeniran, 2016). The invasion of Plasmodium parasite into the 
RBCs (ring stage) requires energy consumption which increases during maturity (trophozoites) 
(Kirk, 2001). A slight decrease in glucose concentration observed at day 7 PI may suggest the 
invasion of RBCs by P. berghei while the persistent decline on day 14 PI coincides with the 
maturity of the trophozoites which needs a large amount of energy. This study showed that Pb 
mono-infection had a blood glucose lowering effect which was not associated to a decrease in liver 
glycogen compared to the other three groups, suggesting that there could have been other 
mechanisms involved such as hepatocyte damage caused by the parasite (Murambirwa et al., 
2013). Several mechanisms have been proposed in previous studies as cause of hypoglycemia, 
such as the depletion of the glyconeogenic substrate, thiamine, by malaria parasite (Krishna et al., 
1999), others include hepatocellular damage caused by the malaria parasite (Murambiwa et al., 
2013). Liver damage is caused by the entry of the parasite into the hepatic cells by in the course 
of replication (Murambiwa et al., 2013). Since the liver plays a major role in the glucose utilization, 
it is therefore certain that damage of the hepatic cells might turn might induce hypoglycemia 
(Onyesom and Agho, 2011). According to Onyesom and Agho (2011) hypoglycemia could also 
be attributed to organ congestion, sinusoidal blockage and inflammation of pancreatic cells. 
Contrary to other studies that has illustrated the occurrence of hypoglycemia during co-infection 
of helminths and malaria (Segura et al., 2009; Ademola and Odeniran, 2016), our study illustrated 
50 
 
that co-infection with T. zimbabwensis may regulate blood glucose lowering effect of P. berghei, 
although the mechanism involved could not be elucidated.  
The current study shows elevated glycogen accumulation in Pb + Tz co-infected muscle cell of 
experimental animals compared to Tz mono-infected rats. This indicates that T. zimbabwensis co-
infection might cause higher glycogen accumulation, however, glycogen accumulation between 
Tz mono-infection and Pb + Tz co-infection was not significant suggesting that T. zimbabwensis 
ML play a vital role on glycogen accumulation in the skeletal muscles (Gottstein et al., 2009) since 
the larvae require more energy for proliferation. A previous study has reported an increase in 
glycogen accumulation at day 8 PI and 18 PI in mice infected with T. spiralis and T. pseudospiralis 
infections and depleted at day 28 PI and 48 PI, although the glycogen accumulation for T. spiralis 
lasted longer than that of T. pseudospiralis infections (Wu et al., 2009). Similarly, our study 
observed steady increases in glycogen accumulation from day 0 PI peaking at day 14 PI, suggesting 
that T. zimbabwensis ML development was demanding higher energy levels. The mechanism 
involved in high glycogen accumulation is still not clear and among the hypothesized mechanisms 
include increase glucose uptake through insulin signaling pathways (Wu et al., 2009). Insulin plays 
a vital role in most insulin-responsive sites by enhancing glucose uptake glucose uptake in striated 
muscles and tissues (Pessin and Saltiel, 2000; Saltiel and Kahn, 2001). 
The co-infection group and Tz mono-infection reduced liver glycogen concentration at day 7 PI 
whereas only the co-infection group still presented a significant decrease at day 14 PI compared 
to the control. Since, the liver plays a major role in glucose homeostasis by breaking down insulin 
receptor complex found at the cell surface where it is internalized for degradation and recycling of 
glucogeogenic substrate back to the membrane, this suggest that depletion of gluconeogenic 
substrate during Pb infection could be attributed to liver damage (Murambiwa et al., 2013). 
According to Dekker et al. (1997), the hepatocellular destruction could occur during the rapid 
multiplication and change of phase within the liver by the malaria parasite. This is supported by 
studies carried out by Kausar et al. (2010) in which they observed an increase in liver enzymes 
such as alkaline transaminases, aspartate, alkaline phosphatase, suggesting the probability of liver 
damage. However, the current study could not investigate the histopathological effect of P. berghei 
parasite on the liver and hence conclusive mechanisms could not be drawn. 
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Results from this study show that the level of serum insulin was reduced in Tz mono-infection and 
Pb + Tz co-infection group compared to control. At day 14 PI the serum insulin level in infected 
groups increases back to normal suggesting that in the later days of the infection the insulin level 
might have been restored by regulating enteritis and pancreatobiliary secretory motor functions 
(Onkoba et al., 2016). Similar observation have been reported in mice infected with T. spiralis and 
T. pseudospiralis (Wu et al., 2009). This is in contrast to another study that shows an increase in 
insulin in mice infected with T. zimbabwensis compared to the control (Onkoba et al., 2016). 
Normally, insulin functions in regulating blood glucose level and when there is an increase in 
blood glucose, insulin is released from the pancreatic β- cells of the islet of Langerhans targeting 
responsive tissues to stimulate glucose uptake (Leto and Saltiel, 2012). However, Wu et al. (2009) 
suggested that the ML in muscle cell exploits the host metabolic processes to increase glucose 
uptake and maintain a high glycogen content in infected muscle cells by increase expression of 
insulin signaling factors in infected muscle cells rather than increasing insulin concentration. 
Therefore, in cases of inadequate release of insulin, alternative mechanism has been reported such 
as intracellular signaling systems that have been modified and are involved in glucose and lipid 
metabolism (Pessin and Saltiel, 2000). Insulin signaling pathways have been suggested to play a 
main role in glucose transportation to responsive tissues and also facilitate the conversion of 
glucose to glycogen in storage organs (Youngren, 2007). Therefore, it can be speculated that the 
observed increased glycogen concentration in muscle tissues in the current study, was not insulin 
dependent, suggesting that there could be other functional mechanism in play. Further research in 
this aspect is recommended to draw an appropriate conclusion. 
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CHAPTER 6: CONCLUSION 
The current study demonstrated that Tz mono-infection and Tz + Pb co-infection did not have 
blood glucose lowering effect in the host. We also reported hypoinsulinemia for the 
aforementioned groups, which was later restored to normal. Co-infected rats with P. berghei and 
T. zimbabwensis resulted in rapid development of Pb parasitaemia than the P. berghei mono-
infection accompanied by decrease in RBC and haematocrit. Additionally, co-infection group 
showed an increase in glycogen content and body weight gain. The fact that hypoglycemia was 
not observed in co-infected male Sprague-Dawley rats suggest that there are other possible 
mechanisms through which tissue dwelling parasite upregulates the glucose store without 
decreasing the blood glucose concentration. This process necessitates further research in order to 
elucidate the specific mechanisms and pathways involved.  
 
6.1 Recommendation 
The results from the current study will contribute to knowledge on how tissue dwelling helminth 
can modulate P. berghei parasite during co-infection while adapting to the hosts metabolism and 
immune system without causing hypoglycemia. Therefore, further study on the histological 
parameters and insulin signaling pathways should be addressed in future research. 
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8. APPENDIX 
8.1 Graph showing the insulin standard curve 
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